Download | < Back |
12 Jan 2017 | |
The Exchange has received the disclosure under Regulation 10(5) in respect of acquisition under Regulation 10(1)(a) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for RPR Sons Advisors Pvt Ltd | |
View all announcements for AUROBINDO PHARMA LTD. | Source: BSE India |